NewsReuters (AI)Sep 16, 2026

Novo partners with Anthropic to accelerate drug development using Claude

Novo teams up with Anthropic to leverage Claude to speed up the drug discovery process from preclinical to clinical development.

Why it mattersHigh potential to reduce time and cost in drug development; signals practical AI adoption in pharma and collaboration models.

industry collaboration drug discovery AI adoption

Read the original →

Related stories

Key Takeaways from GitHub Octoverse 2026 Simon Willison
AI Emergency Notifications Expand, but Are People Ready? WIRED AI
Efforts to Promote Employee AI Use Advance AI regulation & lawsuits
AI adoption accelerates at JIMTOF2026 AI in Japan
Actor Mark Wahlberg talks about AI usage TechCrunch AI
Germany to Consider AI Cooperation with NVIDIA Reuters (AI)

More from Sep 16, 2026

MHI and PFN Form Capital Tie-Up to Boost AI for Disaster Prevention and Defense ITmedia AI+
Claude Code: Key Points for Cost Efficiency and Token Waste Prevention ITmedia AI+
Chiyoda Ward Deploys Generative AI Across All Agencies, Cuts 4,000 Hours Annually ITmedia AI+
Women in AI Talent White Paper 2026: Japan's Current Situation AI in Japan
Anthropic Integrates Claude Chat and Cowork Anthropic coverage
State Education Boards Set AI Rules for Education AI regulation & lawsuits

← Back to AI News